Skip to search formSkip to main contentSkip to account menu

Doxercalciferol

Known as: 1-alpha-hydroxyvitamin D2, 1?-Hydroxyergocalciferol, 1 alpha-hydroxyergocalciferol 
A synthetic analog of vitamin D with potential antineoplastic activity. In the liver, doxercalciferol is converted to its biologically active vitamin… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
We conducted a phase II trial of doxercalciferol, a vitamin D2 analogue, in 15 patients with MDS. Each received doxercalciferol… 
2005
2005
We reported that (23S)-25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactone (TEI-9647) antagonizes vitamin D receptor (VDR… 
2004
2004
OBJECTIVE To study the effectiveness of the vitamin D analogue 1alpha-hydroxyvitamin D(2) (1alpha-OH-D(2)) in inhibiting ocular… 
2003
2003
The synthesis of novel vitamin D receptor antagonists, 24-methyl-1alpha-hydroxyvitamin D(3) 26,23-lactones, is reported. We found… 
2002
2002
BACKGROUND Although calcitriol (1,25-dihydroxycholecalciferol) and vitamin D(2) inhibit retinoblastoma growth in the athymic… 
1995
1995
The vitamin D analog 1 alpha-hydroxyvitamin D2 (1 alpha-OHD2) is under development for the treatment of secondary… 
1982
1982
The efficacy of a health education campaign to improve the vitamin D status of Asians has been assessed. The average daily… 
1978
1978
An efficient procedure for the direct C-1 hydroxylation of vitamin D compounds has been developed. The method involves conversion…